The structural basis of nucleic acid recognition by Toll-like receptors

Toll样受体核酸识别的结构基础

基本信息

  • 批准号:
    8899594
  • 负责人:
  • 金额:
    $ 20.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Toll-like receptors (TLRs) generate an innate immune signaling response upon recognizing broadly conserved microbial extracellular structures. Viral RNA is recognized by TLR3, TLR7 and TLR8, and microbial DNA is recognized by TLR9. Until recently the prevailing paradigm was that TLR9 recognized unmethylated CpG DNA motifs, which are abundant in bacteria but relatively scarce in mammalian DNA. However, recent studies including our own preliminary data suggest that TLR9 binds natural DNA ligands independently of their sequence and methylation state. We propose a comprehensive analysis of the structural properties that allow TLR9 to recognize microbial DNA including sequence, length, duplex content, methylation state, backbone chemistry (phosphodiester versus phosphorothioate), curvature and higher order structure (such as junctions). We show in preliminary studies that DNA curvature-inducing proteins HMGB1 and histones H2A and H2B significantly enhance binding to the C-terminal cleavage fragment of TLR9, suggesting that TLR9 preferentially recognizes curved DNA backbones. To determine the extent to which DNA curvature alone is responsible for the binding enhancement, we propose to measure the TLR9 binding affinity of DNA minicircles containing 75 to 120 base pairs. Since nucleosomes can induce TLR-dependent auto immunogenic signaling, we propose an in vitro biophysical analysis of whole nucleosomes as TLR9 ligands. These in vitro studies will be validated in vivo by measuring TLR9-dependent signaling responses in cells stimulated with various DNA or protein-DNA ligands including minicircles, nucleosomes, junctions and methylated DNA ligands. The TLR7/8/9 ectodomains must be proteolytically cleaved in order to produce receptors that are capable of signaling. In the first study with cleaved TLR9, we show in our preliminary data that both the N- and C-terminal TLR9 ectodomain fragments participate in ligand binding and receptor dimerization. We therefore hypothesize that the two fragments remain associated after proteolytic cleavage in the endosome, and that cleavage may be necessary for TLR9 to undergo the ligand-induced conformational change that activates the receptor. To test this hypothesis, we will explore the physical and functional relationships between the two TLR9 ectodomain fragments, and elucidate the physical basis of proteolytic activation using biophysical approaches. The lack of structural information for TLR7/8/9 limits our understanding of nucleic acid recognition by these receptors. We propose to use electron cryomicroscopy and X-ray crystallography as complementary approaches to gain insight into the structural basis of TLR9-DNA recognition. By providing a molecular-level understanding of the recognition of microbial DNA by TLR9, this project will provide the necessary tools to create more potent vaccine adjuvants, and a new class of anti-inflammatory therapeutics with a wide range of applications including in particular systemic lupus erythematosus, asthma, septic shock syndrome and organ transplant rejection.
描述(由申请人提供):Toll样受体(TLR)在识别广泛保守的微生物细胞外结构后产生先天性免疫信号传导应答。病毒RNA由TLR 3、TLR 7和TLR 8识别,微生物DNA由TLR 9识别。直到最近,流行的范例是TLR 9识别未甲基化的CpG DNA基序,其在细菌中丰富,但在哺乳动物DNA中相对稀少。然而,最近的研究,包括我们自己的初步数据表明,TLR 9结合天然DNA配体独立于它们的序列和甲基化状态。我们提出了一个全面的分析的结构特性,允许TLR 9识别微生物DNA,包括序列,长度,双链体含量,甲基化状态,骨架化学(磷酸二酯与硫代磷酸酯),曲率和更高的顺序结构(如路口)。我们表明,在初步研究中,DNA弯曲诱导蛋白HMGB 1和组蛋白H2 A和H2 B显着增强结合TLR 9的C-末端切割片段,这表明TLR 9优先识别弯曲的DNA骨架。为了确定在何种程度上,DNA曲率单独负责的结合增强,我们建议测量TLR 9的结合亲和力的DNA小环含有75至120个碱基对。由于核小体可以诱导TLR依赖的自身免疫原性信号,我们提出了一个体外生物物理分析的整个核小体作为TLR 9配体。这些体外研究将通过测量用各种DNA或蛋白质-DNA配体(包括微环、核小体、连接和甲基化DNA配体)刺激的细胞中的TLR 9依赖性信号传导应答来在体内验证。TLR 7/8/9胞外域必须被蛋白水解切割以产生能够信号传导的受体。在第一项研究中,裂解的TLR 9,我们在我们的初步数据表明,N-和C-末端TLR 9胞外域片段参与配体结合和受体二聚化。因此,我们假设这两个片段在内体中蛋白水解切割后保持相关,并且切割可能是TLR 9进行激活受体的配体诱导的构象变化所必需的。为了验证这一假设,我们将探讨两个TLR 9胞外域片段之间的物理和功能关系,并阐明蛋白水解激活的物理基础,使用生物物理方法。TLR 7/8/9结构信息的缺乏限制了我们对这些受体的核酸识别的理解。我们建议使用电子低温显微镜和X射线晶体学作为互补的方法来深入了解TLR 9-DNA识别的结构基础。通过提供TLR 9识别微生物DNA的分子水平的理解,该项目将提供必要的工具来创建更有效的疫苗佐剂,以及一类新的抗炎治疗药物,其应用范围广泛,特别是系统性红斑狼疮,哮喘,脓毒性休克综合征和器官移植排斥反应。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Endosomal vesicles as vehicles for viral genomes.
  • DOI:
    10.1016/j.tcb.2014.03.006
  • 发表时间:
    2014-08
  • 期刊:
  • 影响因子:
    19
  • 作者:
    Nour, Adel M.;Modis, Yorgo
  • 通讯作者:
    Modis, Yorgo
P(I) Release Limits the Intrinsic and RNA-Stimulated ATPase Cycles of DEAD-Box Protein 5 (Dbp5).
  • DOI:
    10.1016/j.jmb.2015.12.018
  • 发表时间:
    2016-01-29
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Wong EV;Cao W;Vörös J;Merchant M;Modis Y;Hackney DD;Montpetit B;De La Cruz EM
  • 通讯作者:
    De La Cruz EM
A bioactive phlebovirus-like envelope protein in a hookworm endogenous virus.
  • DOI:
    10.1126/sciadv.abj6894
  • 发表时间:
    2022-05-13
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Merchant, Monique;Mata, Carlos P.;Liu, Yangci;Zhai, Haoming;Protasio, Anna, V;Modis, Yorgo
  • 通讯作者:
    Modis, Yorgo
An Inheritable variant of the innate immune receptor melanoma differentiation-associated gene 5 promotes clearance of hepatitis C virus.
先天免疫受体黑色素瘤分化相关基因 5 的可遗传变体可促进丙型肝炎病毒的清除。
  • DOI:
    10.1002/hep.27439
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Modis,Yorgo
  • 通讯作者:
    Modis,Yorgo
RNA:DNA hybrids are a novel molecular pattern sensed by TLR9.
  • DOI:
    10.1002/embj.201386117
  • 发表时间:
    2014-03-18
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Rigby, Rachel E.;Webb, Lauren M.;Mackenzie, Karen J.;Li, Yue;Leitch, Andrea;Reijns, Martin A. M.;Lundie, Rachel J.;Revuelta, Ailsa;Davidson, Donald J.;Diebold, Sandra;Modis, Yorgo;MacDonald, Andrew S.;Jackson, Andrew P.
  • 通讯作者:
    Jackson, Andrew P.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yorgo Modis其他文献

Yorgo Modis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yorgo Modis', 18)}}的其他基金

The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
  • 批准号:
    8518408
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
  • 批准号:
    8978926
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
  • 批准号:
    8345738
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
The structural basis of nucleic acid recognition by Toll-like receptors
Toll样受体核酸识别的结构基础
  • 批准号:
    8704350
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
SOLUTION STRUCTURE STUDIES OF MDA5 AND OTHER RIG-I LIKE RECEPTORS
MDA5 和其他 RIG-I 样受体的溶液结构研究
  • 批准号:
    8363548
  • 财政年份:
    2011
  • 资助金额:
    $ 20.79万
  • 项目类别:
STRUCTURAL BASIS OF INNATE IMMUNE RECOGNITION OF TOXOPLASMA GONDII
弓形虫先天免疫识别的结构基础
  • 批准号:
    8361693
  • 财政年份:
    2011
  • 资助金额:
    $ 20.79万
  • 项目类别:
STRUCTURE OF PESTIVIRUS ENVELOPE PROTEINS
瘟病毒包膜蛋白的结构
  • 批准号:
    8361635
  • 财政年份:
    2011
  • 资助金额:
    $ 20.79万
  • 项目类别:
MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
  • 批准号:
    8170596
  • 财政年份:
    2010
  • 资助金额:
    $ 20.79万
  • 项目类别:
MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
  • 批准号:
    7955157
  • 财政年份:
    2009
  • 资助金额:
    $ 20.79万
  • 项目类别:
MICROBIAL LIGAND RECOGNITION BY INNATE IMMUNE SENSORS
先天免疫传感器识别微生物配体
  • 批准号:
    7957282
  • 财政年份:
    2009
  • 资助金额:
    $ 20.79万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 20.79万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 20.79万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 20.79万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 20.79万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 20.79万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 20.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了